Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

When it comes to managing type 2 diabetes and supporting weight loss, patients often face the choice between Semaglutide ...

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...

What you need to know about weight-loss injections, including the difference between Wegovy and Ozempic, NHS vs private ...

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal ...

Novo Nordisk, maker of Ozempic and Wegovy, now has a market capitalization of more than ... paying patients who are willing ...

Investors have sent stocks and bonds higher on expectations of a soft landing. But some Republicans think the central bank ...

The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...